Improving patient identification for advanced cardiac imaging through machine learning-integration of clinical and coronary CT angiography data

Incremental prognostic value of downstream positron emission tomography perfusion imaging after coronary computed tomography angiography: a study using machine learning

AIMS

To evaluate the incremental value of positron emission tomography (PET) myocardial perfusion imaging (MPI) over coronary computed tomography angiography (CCTA) in predicting short- and long-term outcome using machine learning (ML) approaches.

METHODS AND RESULTS

A total of 2411 patients with clinically suspected coronary artery disease (CAD) underwent CCTA, out of whom 891 patients were admitted to downstream PET MPI for haemodynamic evaluation of obstructive coronary stenosis. Two sets of Extreme Gradient Boosting (XGBoost) ML models were trained, one with all the clinical and imaging variables (including PET) and the other with only clinical and CCTA-based variables. Difference in the performance of the two sets was analysed by means of area under the receiver operating characteristic curve (AUC). After the removal of incomplete data entries, 2284 patients remained for further analysis. During the 8-year follow-up, 210 adverse events occurred including 59 myocardial infarctions, 35 unstable angina pectoris, and 116 deaths. The PET MPI data improved the outcome prediction over CCTA during the first 4 years of the observation time and the highest AUC was at the observation time of Year 1 (0.82, 95% confidence interval 0.804-0.827). After that, there was no significant incremental prognostic value by PET MPI.

CONCLUSION

PET MPI variables improve the prediction of adverse events beyond CCTA imaging alone for the first 4 years of follow-up. This illustrates the complementary nature of anatomic and functional information in predicting the outcome of patients with suspected CAD.

Classification models for assessing coronary artery disease instances using clinical and biometric data: an explainable man-in-the-loop approach

The main goal driving this work is to develop computer-aided classification models relying on clinical data to identify coronary artery disease (CAD) instances with high accuracy while incorporating the expert's opinion as input, making it a "man-in-the-loop" approach. CAD is traditionally diagnosed in a definite manner by Invasive Coronary Angiography (ICA). A dataset was created using biometric and clinical data from 571 patients (21 total features, 43% ICA-confirmed CAD instances) along with the expert's diagnostic yield. Five machine learning classification algorithms were applied to the dataset. For the selection of the best feature set for each algorithm, three different parameter selection algorithms were used. Each ML model's performance was evaluated using common metrics, and the best resulting feature set for each is presented. A stratified ten-fold validation was used for the performance evaluation. This procedure was run both using the assessments of experts/doctors as input and without them. The significance of this paper lies in its innovative approach of incorporating the expert's opinion as input in the classification process, making it a "man-in-the-loop" approach. This approach not only increases the accuracy of the models but also provides an added layer of explainability and transparency, allowing for greater trust and confidence in the results. Maximum achievable accuracy, sensitivity, and specificity are 83.02%, 90.32%, and 85.49% when using the expert's diagnosis as input, compared to 78.29%, 76.61%, and 86.07% without the expert's diagnosis. The results of this study demonstrate the potential for this approach to improve the diagnosis of CAD and highlight the importance of considering the role of human expertise in the development of computer-aided classification models.

Introduction to radiomics for a clinical audience

Radiomics is a rapidly developing field of research focused on the extraction of quantitative features from medical images, thus converting these digital images into minable, high-dimensional data, which offer unique biological information that can enhance our understanding of disease processes and provide clinical decision support. To date, most radiomics research has been focused on oncological applications; however, it is increasingly being used in a raft of other diseases. This review gives an overview of radiomics for a clinical audience, including the radiomics pipeline and the common pitfalls associated with each stage. Key studies in oncology are presented with a focus on both those that use radiomics analysis alone and those that integrate its use with other multimodal data streams. Importantly, clinical applications outside oncology are also presented. Finally, we conclude by offering a vision for radiomics research in the future, including how it might impact our practice as radiologists.

Radiogenomics and Artificial Intelligence Approaches Applied to Cardiac Computed Tomography Angiography and Cardiac Magnetic Resonance for Precision Medicine in Coronary Heart Disease: A Systematic Review

The risk of coronary heart disease (CHD) clinical manifestations and patient management is estimated according to risk scores accounting multifactorial risk factors, thus failing to cover the individual cardiovascular risk. Technological improvements in the field of medical imaging, in particular, in cardiac computed tomography angiography and cardiac magnetic resonance protocols, laid the development of radiogenomics. Radiogenomics aims to integrate a huge number of imaging features and molecular profiles to identify optimal radiomic/biomarker signatures. In addition, supervised and unsupervised artificial intelligence algorithms have the potential to combine different layers of data (imaging parameters and features, clinical variables and biomarkers) and elaborate complex and specific CHD risk models allowing more accurate diagnosis and reliable prognosis prediction. Literature from the past 5 years was systematically collected from PubMed and Scopus databases, and 60 studies were selected. We speculated the applicability of radiogenomics and artificial intelligence through the application of machine learning algorithms to identify CHD and characterize atherosclerotic lesions and myocardial abnormalities. Radiomic features extracted by cardiac computed tomography angiography and cardiac magnetic resonance showed good diagnostic accuracy for the identification of coronary plaques and myocardium structure; on the other hand, few studies exploited radiogenomics integration, thus suggesting further research efforts in this field. Cardiac computed tomography angiography resulted the most used noninvasive imaging modality for artificial intelligence applications. Several studies provided high performance for CHD diagnosis, classification, and prognostic assessment even though several efforts are still needed to validate and standardize algorithms for CHD patient routine according to good medical practice.